PrecisionLife logo

PrecisionLife

AI-driven precision medicine for complex, chronic diseases. Creating better diagnostics & more personalized treatments.

33 employees · est. 2015 · Oxford, United Kingdom

VS
SynapCell logo

SynapCell

Evaluate your most effective drug candidates in vivo using objective & translational measurements in the brain. #EEG

41 employees · est. 2005 · Boston, France

SynapCell is the older company (2015 vs 2005).

Side-by-Side Comparison

PrecisionLife SynapCell
Founded
2015 2005 older
Headquarters
Oxford, United Kingdom Boston, France
Employees
33 41
Industry
Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Grant Series A
Total Funding
$2.50M $4.40M
Funding Rounds
2 1
Services
AI-led Precision Medicine Platform, Disease Biology Insights, Drug Development Support, Clinical Decision Support Tools Drug Efficacy Testing, Collaborative Projects, Preclinical EEG Lab Services, EEG Biomarker Analysis, Model Exploration
Target Customers
Biopharmaceutical Companies, Healthcare Institutions, Clinical Research Organizations, Medical Professionals Pharmaceutical Companies, Biotechnology Firms, Neuroscience Researchers, Drug Discovery Teams, Academia in CNS Research
Taxonomy
Precision Medicine, Drug Discovery, Clinical Research, Biomarkers, Diagnostics, Chronic Diseases, Patient Stratification, Clinical Decision Support, Drug Development, Biopharma, Combinatorial Analytics, Novel Target Discovery CNS Drug Development, EEG Biomarkers, Neuroscience, Preclinical Evaluation, Drug Discovery Solutions, Central Nervous System, Biomarker Identification, Pharmacodynamics, Translational Models, Pharmaco-EEG, Epilepsy, Parkinson's Disease, Essential Tremors, Schizophrenia, Neural Network
Website
precisionlife.com synapcell.com
PrecisionLife logo

About PrecisionLife

PrecisionLife is a clinical-stage precision medicine company focusing on better diagnostic tools and more personalized treatment options for predicting, treating, and preventing complex chronic diseases. Their AI-led platform is unmatched in understanding disease biology and identifying underlying c...

SynapCell logo

About SynapCell

SynapCell is a biotechnology company founded in 2005, specializing in drug efficacy evaluation at the preclinical stage using EEG-based methods. Their innovative approach provides drug developers with quantitative and unbiased endpoints through longitudinal monitoring of drug effects on translationa...

We will tell you when either one moves

BounceWatch watches PrecisionLife and SynapCell for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at PrecisionLife and SynapCell — by email.

Frequently Asked Questions

PrecisionLife — AI-driven precision medicine for complex, chronic diseases. Creating better diagnostics & more personalized treatments.. SynapCell — Evaluate your most effective drug candidates in vivo using objective & translational measurements in the brain. #EEG. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
PrecisionLife has raised $2.50M while SynapCell has raised $4.40M.
PrecisionLife and SynapCell operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare PrecisionLife with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at PrecisionLife on 24 Feb 2025, and SynapCell on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy